Autism ALERT: Autism Access Link for Early Referral and Treatment

Sponsor
Oregon Health and Science University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04861740
Collaborator
Boston Medical Center (Other), Providence Health & Services (Other)
170
1
2
14.4
11.8

Study Details

Study Description

Brief Summary

Autism Access Link for Early Referral and Treatment [ALERT], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process. We hypothesize that Autism ALERT will have strong acceptability and high rates of use among primary care providers as well as among diverse low-income patients of children at risk for ASD, and that we will see higher rates of child ASD educational evaluations within six months, and shorter time between referral and ASD treatment, compared with our control.

Condition or Disease Intervention/Treatment Phase
  • Other: Autism ALERT
  • Other: Screening Intervention
N/A

Detailed Description

Though significant research effort has focused on autism spectrum disorder (ASD) screening, less attention has been devoted to optimizing follow-up of children who are subsequently identified as at-risk. Despite increases in ASD screening rates, many children with ASD wait years between when autism is suspected in the primary care setting and when definitive diagnosis and treatment begin. Delayed and missed diagnoses are particularly problematic for low-income and racial/ethnic minority children in the US, who experience higher rates of these adverse outcomes. In this project, we propose to pilot test Autism Access Link to Early Referral and Treatment (Autism ALERT), a statewide monitoring and case management program to accelerate access to ASD diagnosis and treatment among children with suspected ASD the primary care setting. The system will reduce the time between identification of suspected ASD in the primary care setting and establishment of ASD diagnosis and treatment services, by reducing family barriers to care, decreasing primary care provider burdens, and simplifying referral processes. The program will be available to any Oregon child age 12-54 months, regardless of health system or payor type. Autism ALERT will become part of the Help Me Grow national network, which gives it potential for statewide and national spread. In this proposed research, we will pilot test Autism ALERT by comparing it to an existing ASD screening intervention in 6 Oregon primary care practices. Primary goals of this pilot project are to assess feasibility and acceptability of Autism ALERT for primary care providers and families, to test the mechanism of action of Autism ALERT, to pilot test efficacy in reducing time to autism diagnosis and treatment, and to test fidelity of protocol implementation. If successful, this project will be expanded into an implementation/effectiveness R01 in which the program will be tested throughout the state of Oregon. In the long term, this research will result in a sustainable, evidence-based statewide and ultimately national monitoring system children with suspected ASD.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
170 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
We propose a pilot clustered interventional trial with two arms. Clinics in the intervention arm (Screening + Autism ALERT) receive Autism ALERT plus an ASD screening intervention, and clinics in the comparison intervention arm (Screening Only) receive the ASD screening intervention only (START Autism). As this is a pilot trial, primary outcomes of interest are feasibility and acceptability. We will additionally assess mechanism of outcome, preliminary efficacy, and protocol fidelity. Feasibility and acceptability will be assessed in intervention clinics. Mechanism of action and preliminary efficacy will be assessed by comparing intervention to control clinics. Fidelity is assessed in both arms. We will pilot test Autism ALERT in 6 safety-net primary care clinics in Oregon.We propose a pilot clustered interventional trial with two arms. Clinics in the intervention arm (Screening + Autism ALERT) receive Autism ALERT plus an ASD screening intervention, and clinics in the comparison intervention arm (Screening Only) receive the ASD screening intervention only (START Autism). As this is a pilot trial, primary outcomes of interest are feasibility and acceptability. We will additionally assess mechanism of outcome, preliminary efficacy, and protocol fidelity. Feasibility and acceptability will be assessed in intervention clinics. Mechanism of action and preliminary efficacy will be assessed by comparing intervention to control clinics. Fidelity is assessed in both arms. We will pilot test Autism ALERT in 6 safety-net primary care clinics in Oregon.
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Autism Access Link for Early Referral and Treatment
Actual Study Start Date :
Mar 18, 2021
Anticipated Primary Completion Date :
May 31, 2022
Anticipated Study Completion Date :
May 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Screening + Autism ALERT

Clinics in the intervention arm receive Autism ALERT plus an ASD screening intervention (START Autism).

Other: Autism ALERT
Autism Access Link for Early Referral and Treatment [ALERT], the intervention proposed in this application, is a novel state-wide referral and case management platform that PCPs can activate to ensure that a child with suspected ASD receives all necessary ASD diagnosis and treatment resources in a single referral, radically simplifying a complex diagnostic and treatment process.

Other: Screening Intervention
Autism screening intervention only.
Other Names:
  • START Autism
  • Active Comparator: Screening Only

    Clinics in the comparison intervention (control) arm receive the ASD screening intervention only (START Autism).

    Other: Screening Intervention
    Autism screening intervention only.
    Other Names:
  • START Autism
  • Outcome Measures

    Primary Outcome Measures

    1. Change in satisfaction with Care Coordination in general and for autism in particular [At enrollment and study end (~9 months after enrollment)]

      2 separate provider survey measures

    2. Change in Parent stress [At enrollment and 6 months after enrollment]

      Parent Survey - Parenting Stress Index

    3. Change in Parenting stress [At enrollment and 6 months after enrollment]

      Questionnaire on Resources and stress - Short Form

    4. Change in Family Empowerment [At enrollment and 6 months after enrollment]

      Parent Survey - Family Empowerment Scale, Family Subscale

    5. Change in Family Centered and Coordinated Care [At enrollment and 6 months after enrollment]

      Parent Survey - Items from National Survey of Children's Health, Medical Home item set

    6. Family Satisfaction with Program [6 months after enrollment - Autism ALERT + Screening arm only]

      Parent Survey items - Satisfaction with Interpersonal Relationship with Navigator (PSN-I), Client Satisfaction Questionnaire - 8

    7. % referred to program who complete an ASD educational evaluation within 6 months [6 months after enrollment]

      Administrative data - Oregon Early Intervention/Early Childhood Special Ed (EI/ECSE) database

    8. Time from EI/ECSE referral to ASD treatment in EI/ECSE, among children with ASD [measured 9 months after enrollment]

      Administrative data - Oregon EI/ECSE database

    9. Family self-reported ASD knowledge [At enrollment and 9 months after enrollment]

      5-item survey measure

    10. Change in provider self-efficacy about autism management [At enrollment and at study end (~9 months after enrollment)]

      1-item survey measure

    Secondary Outcome Measures

    1. Change in provider autism paperwork burden [At enrollment and at study end (~9 months after enrollment)]

      Provider survey item

    2. Time from EI/ECSE referral to evaluation among children with ASD [measured 9 months after enrollment]

      Administrative data - Oregon EI/ECSE database

    3. Age of EI/ECSE educational determination, among children with ASD [measured 9 months after enrollment]

      Administrative data - Oregon EI/ECSE database

    4. % with ASD determination receiving ASD services 6 months after enrollment [measured 9 months after enrollment]

      Administrative data - Oregon EI/ECSE database

    5. monthly service hours among children with ASD 6 months after enrollment [measured 9 months after enrollment]

      Administrative data - Oregon EI/ECSE database

    6. age of ASD medical diagnosis among children on Medicaid [Measured 1 year after study enrollment]

      Administrative data - Medicaid claims

    7. % with ASD medical diagnosis receiving ASD therapy 6 months after enrollment, among children on Medicaid [Measured 1 year after study enrollment]

      Administrative data - Medicaid claims

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Months to 54 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    child's primary care provider suspects the child has ASD, child is patient at one of the study clinics, child age 12 to 54 months, family speaks English or Spanish, no prior ASD medical diagnosis or ASD diagnostic evaluation

    Exclusion Criteria:

    Previous diagnosis of ASD or prior diagnostic evaluation for ASD.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ohsu Cdrc Portland Oregon United States 97239

    Sponsors and Collaborators

    • Oregon Health and Science University
    • Boston Medical Center
    • Providence Health & Services

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Katharine Zuckerman, Principal Investigator, Oregon Health and Science University
    ClinicalTrials.gov Identifier:
    NCT04861740
    Other Study ID Numbers:
    • 00001
    First Posted:
    Apr 27, 2021
    Last Update Posted:
    Jul 21, 2021
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Katharine Zuckerman, Principal Investigator, Oregon Health and Science University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 21, 2021